Filing Details
- Accession Number:
- 0001127602-23-021080
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-20 16:17:43
- Reporting Period:
- 2023-07-18
- Accepted Time:
- 2023-07-20 16:17:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
313143 | Haemonetics Corp | HAE | Surgical & Medical Instruments & Apparatus (3841) | 042882273 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1750812 | Josep Llorens | 125 Summer Street Boston MA 02110 | Evp, Global Manufacturing | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-07-18 | 2,391 | $56.57 | 20,854 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-07-18 | 2,537 | $57.60 | 23,391 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-07-18 | 4,928 | $90.00 | 18,463 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2023-07-18 | 2,391 | $0.00 | 2,391 | $56.57 |
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2023-07-18 | 2,537 | $0.00 | 2,537 | $57.60 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
4,782 | 2022-05-18 | 2028-05-18 | No | 4 | M | Direct |
7,611 | 2023-05-16 | 2029-05-16 | No | 4 | M | Direct |
Footnotes
- Transaction pursuant to an existing 10b5-1 trading plan dated August 22, 2022.
- This number includes unvested restricted stock units previously reported.
- Option vests in annual increments of 25% beginning on the first anniversary of the date of grant.